Propanc Biopharma Inc (PPCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15 | 9 | 21 | 6 | 72 |
| Receivables | 2 | 3 | 3 | 5 | 4 |
| Other current assets | 0 | 0 | 1 | 0 | 123 |
| TOTAL | $18 | $22 | $25 | $13 | $211 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 61 | 42 | 47 | 25 | 31 |
| TOTAL | $61 | $42 | $47 | $25 | $31 |
| Total Assets | $79 | $64 | $72 | $37 | $242 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 541 | 424 | 266 | 146 | 132 |
| Accounts payable and accrued liabilities | 1,223 | 1,239 | 1,213 | 1,188 | 1,158 |
| Accrued Expenses | 1,035 | 987 | 887 | 849 | 756 |
| Other current liabilities | 770 | 843 | 803 | 768 | 874 |
| TOTAL | $4,155 | $4,101 | $3,793 | $3,688 | $3,762 |
| Non-Current Liabilities | |||||
| Long Term Debt | 82 | 71 | 59 | 47 | 35 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 2 | 8 |
| TOTAL | $82 | $71 | $59 | $49 | $43 |
| Total Liabilities | $4,237 | $4,172 | $3,851 | $3,737 | $3,806 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1 | 789,899 | 688,022 | 167,979 | 52,145 |
| Common Shares | 0 | 688 | 0 | 110 | 36 |
| Retained earnings | -67,483 | -67,053 | -66,698 | -66,340 | -65,797 |
| Other shareholders' equity | 1,445 | 1,124 | 1,223 | 1,293 | 1,179 |
| TOTAL | $-4,159 | $-4,108 | $-3,779 | $-3,700 | $-3,564 |
| Total Liabilities And Equity | $79 | $64 | $72 | $37 | $242 |